Effect of a Multicomponent Intervention on Functional Capacity After Hip Fracture

NCT ID: NCT05435534

Last Updated: 2022-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

174 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-26

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Due to the clinical, functional, cognitive and social complexity of older adults after fragility hip fractures (defined as those produced by low-impact trauma), the investigators propose an intervention.

This intervention involves a multidisciplinary and multicomponent program consisting of physical exercise with tele-rehabilitation, nutritional assessment and other variables related to comprehensive geriatric assessment.

The investigators want to improve functional status, quality of life and prevent new fractures. In addition, the investigators try to optimize treatments and resources based on the functional status of patients and their life expectancies, improving care and healthcare cost

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study aims

1. Improve functional capacity (Short Physical Performance Battery, SPPB) in older patients with fragility hip fractures through a multidisciplinary and multicomponent program and increase the quality of life (EuroQol-5 Dimension) and reduce the use of resources (admission and readmission to emergency department or in-hospital) at 3, 6 and 12 months compare with usual care
2. Analyze the subgroups of patients that benefit the most from the respective interventions, identifying factors of the patient (sociodemographic, clinical, functional and cognitive) and of the intervention (type of exercise, nutritional supplementation, pain control, etc.), which could explain differences in the effectiveness of the intervention at 3, 6 and 12 months
3. Analyze the effect of multidisciplinary and multicomponent intervention in older adults with hip fracture on cognitive capacity (4-AT, MMSE), risk of falls (number of falls, Falls Efficacy Scale), depression (GDS), pain (VAS), polypharmacy, geriatric syndromes and nutritional status (MNA) compare with usual care at 3, 6 and 12 months
4. Developmentally monitor the changes achieved through the intervention, as well as the factors that determine the perpetuation of the benefits of the long-term.
5. Examine the effect of a multi-component program on muscle mass (DXA), bone formation and resorption (BTMs) at 12 months
6. Estimate the prevalence of frailty, multimorbidity and geriatric syndromes in older adults with fragility hip fracture and the changing at 3, 6 and 12 months.
7. Estimate the use of resources necessary to carry out the intervention program, as well as the average time to carry out the comprehensive geriatric assessment, and which is the most cost/efficient tool in this case.
8. Examine the applicability of a tele-rehabilitation program (ActiveHip) in older adults with hip fracture.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures Osteoporosis Fall Frailty Syndrome Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multicomponent intervention

Participants randomly assigned to the Multicomponent intervention group will received a multifactorial intervention.

Group Type EXPERIMENTAL

ActiveFLS intervention

Intervention Type OTHER

* A comprehensive geriatric assessment with a multicomponent physical exercise program guideline based on ActiveHip+ for 3 months. In the subsequent revisions, exercise guidelines from the Vivifrail program will be given
* A protocolized nutritional intervention will be carried out. In case of oral nutritional supplementation, supplements enriched in β-hydroxy-β-methylbutyrate (HMB) will be selected
* Osteoporosis treatments according to national guideline
* A review and adaptation of the treatment will be carried out according to the STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert to Right Treatment) criteria
* An approach will be made to the patient's mood and fear of falling. In case of depression, both pharmacological and non-pharmacological approaches will be assessed
* Screening for cognitive impairment will be performed. In the event of evidence of memory problems, a recommendations for cognitive stimulation will be delivered

Usual care group

Participants randomly assigned to the usual care group will received normal outpatient care, including physical rehabilitation when needed.

Group Type ACTIVE_COMPARATOR

Usual care group

Intervention Type OTHER

Participants randomly assigned to the usual care group will receive normal outpatient care, including physical rehabilitation when needed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ActiveFLS intervention

* A comprehensive geriatric assessment with a multicomponent physical exercise program guideline based on ActiveHip+ for 3 months. In the subsequent revisions, exercise guidelines from the Vivifrail program will be given
* A protocolized nutritional intervention will be carried out. In case of oral nutritional supplementation, supplements enriched in β-hydroxy-β-methylbutyrate (HMB) will be selected
* Osteoporosis treatments according to national guideline
* A review and adaptation of the treatment will be carried out according to the STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert to Right Treatment) criteria
* An approach will be made to the patient's mood and fear of falling. In case of depression, both pharmacological and non-pharmacological approaches will be assessed
* Screening for cognitive impairment will be performed. In the event of evidence of memory problems, a recommendations for cognitive stimulation will be delivered

Intervention Type OTHER

Usual care group

Participants randomly assigned to the usual care group will receive normal outpatient care, including physical rehabilitation when needed.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged ≥ 75 years.
* Diagnosis of frailty hip fracture (those produced by low-impact trauma).
* Absence of terminal-stage disease
* Barthel scale score ≥ 60 points.
* Previous independence for wandering measured as FAC ≥6
* Capability/Support for using ActiveHip+ app

Exclusion Criteria

* Moderate-severe cognitive impairment considered as a Goldberg Global Deterioration Scale score ≥ 5.
* Refusal to sign the informed consent by the patient / main caregiver / legal guardian or inability to obtain it
* Secondary osteoporosis
* Nursing home
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital of Navarra

OTHER

Sponsor Role collaborator

NavarraBiomed Biomedical Research Center

OTHER

Sponsor Role collaborator

Fundacion Miguel Servet

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicolas Martinez-Velilla, PhD

Role: STUDY_DIRECTOR

Fundación Instituto de Investigación Sanitaria de Navarra

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario de Navarra (HUN)

Pamplona, Navarre, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bernardo A Cedeno-Veloz, MD

Role: CONTACT

+34 637418620

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bernardo Cedeno-Veloz, MD

Role: primary

T +(34) 637418620

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ActiveFLS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

'Rehabilitation for Life'
NCT04424186 COMPLETED NA
Rehabilitation in the Home After Hip Fracture
NCT06980129 NOT_YET_RECRUITING NA